Criteria for Covid-19 treatment with Paxlovid?
The food and Drug Administration (FDA) has authorized Paxlovid for the treatment of symptomatic mild to moderate COVID-19. You can be treated with Paxlovid if you are an adult ≥65 years old, have a history of an immunocompromising condition, have multiple risk factors for progression to severe disease, or are an adult ≥50 years old […]